Navigation Links
Long-acting insulin analogues in type 2 diabetes: advantage over human insulin not proven
Date:4/3/2009

studies within the framework of intensified insulin therapy. One study investigated various treatment schemes. This study on insulin glargine lasted 5 years; all the other studies lasted a maximum of 12 months.

It is notable that in 7 of the 9 studies comparing insulin glargine and human insulin, the drugs were not used as normally used in Germany. The study participants only injected the drugs once daily, even though in daily practice they are often injected more frequently. The relevance of these studies is therefore limited.

Conclusions about late complications of diabetes are hardly possible

It is not possible to draw reliable conclusions about the long-term advantages and disadvantages of the drugs investigated, solely due to the short duration of most studies. Even the 5-year study on insulin glargine, the results of which were not available at the time of the preparation of the preliminary report, only allows limited conclusions about late complications of diabetes. Regarding heart disease, the comparison with NPH insulin does not provide indications of a difference between treatment options. Similarly, the data do not provide indications that insulin glargine is associated with a higher risk of damage to the ocular fundus. This suspicion had prompted the US regulatory authority FDA (Food and Drug Administration) to request a long-term study from the manufacturer (Sanofi-Aventis). This study has now been completed and is assessed in the IQWiG report.

Data provide an indication of less frequent severe hypoglycaemia in patients using insulin glargine

The data do not prove short-term advantages of LAIAs, either. However, the data do provide some indications: in certain treatment schemes, non-severe hypoglycaemia seems to occur less frequently with insulin detemir, in consideration of the individual lowering of HbA1c levels. However, this only applies to the use as basal insulin (once or twice daily) i
'/>"/>

Contact: Dr. Anna-Sabine Ernst
info@iqwig.de
Institute for Quality and Efficiency in Health Care
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. US Back Pain Market Approaches $23 Billion in 2018 - Anticipated Long-Acting, Abuse-Resistant Opioids Drive Value
2. Inspirational Teams of Athletes with Diabetes Build Momentum in 2009 with Sponsorship from Long-Acting Insulin Lantus(R) and Rapid-Acting Insulin Apidra(R)
3. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
4. Studies Ignite Hope for Long-Acting Allergy Vaccines
5. FDA Issues Not-Approvable Letter for Lillys Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
6. Plain-Language Guides Detail Insulin Treatments
7. OmniPod(R) Insulin Management System Wins 2009 Edison Best New Product Award
8. NICE SUGAR: Intensive insulin therapy risks
9. Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan
10. Gene Explains How High-Fructose Diets Lead to Insulin Resistance
11. Ethnicity May Drive Response to Obesity, Insulin Resistance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... promoting the establishment of telemedicine programs in communities throughout Georgia, announces the launch ... living in the rural communities of Hancock County, GA. The new program will ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... firm, today announced that TimberNook ( http://www.timbernook.com/ ) has selected the ... strategy, and marketing launch package for new camp providers. TimberNook is a ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... executive Ellen Purdy as the company’s new Chief Financial Officer, effective July 6th, ... leadership experience in companies ranging from a multi-billion dollar, global chemical company to ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... body as designated by the Centers for Medicare and Medicaid Services (CMS), announces ... enhance compatibility with mobile devices. , The most effective websites are those that ...
(Date:7/7/2015)... ... July 07, 2015 , ... On May 29, 2015, Health Canada announced ... use of gluten-free claims for gluten free oats and foods that contain them as ... Certification Program (GFCP) to include gluten-free oat products in Canada,” says Frank Massong, ...
Breaking Medicine News(10 mins):Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:Office Practicum Announces new CFO 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 2Health News:RadSite Releases Mobile-friendly Website for Enhanced User Experience 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4
... in Pune declared Tuesday there is no Hantavirus in the ... south Gujarat.// ,Additional director of NIV, M.S. Chaddha ... not even a single sample contained Hantavirus." ,The ... why two persons had died last week. Dipak Tarsariya (24) ...
... St. Louis and other institutions have reported that experimental ... (PXR) my help in the treatment of Niemann-Pick type ... that is often fatal within the first two decades ... model for Niemann-Pick type C (NPC) disease showed that ...
... published in the August 26 issue of "The Lancet" ... increased over the past decade// in many countries of ... ,Innes Asher from University of Auckland, New Zealand, and ... in Childhood (ISAAC) between 2002-2003 to assess the global ...
... was held recently in Toronto. Around 24,000 scientists and ... emphasized that development of poor countries relies on the ... also in the rich countries. ,Around 5 years ... treat people in poor countries who were infected with ...
... Christchurch General Practitioner for allegedly manipulating a sexual relationship ... the GP even bought her lingerie and advised her ... ,The doctor has been slapped with a charge of ... the woman in question. Allegedly, the former GP ...
... Health Officials said on Monday that scientist have developed a ... up diagnosis of the most dangerous avian flu to less ... any laboratory that can amplify bits of genetic material, and ... material from many different flu strains that can reveal which ...
Cached Medicine News:Health News:Drugs Activating PXR May Help In Treating Niemann-Pick type C disease 2Health News:Drugs Activating PXR May Help In Treating Niemann-Pick type C disease 3Health News:Rise In Childhood Allergies 2Health News:Fighting AIDS – a joint venture of the rich and the poor 2
(Date:7/6/2015)... 6, 2015  EndoChoice Holdings, Inc. (NYSE:  GI) announced ... financial results on Thursday, August 6, 2015 before the ... conference call on Thursday, August 6, 2015 at 9:00 ... are (866) 807-9684 for domestic callers and (412) 317-5415 ... call will be available on the investor relations section ...
(Date:7/6/2015)... , July 6, 2015 Flower ... fixation concept the FlowerCube™, announced today that it ... the opportunity for significant expansion of the innovative ... The approval encompasses Flower Orthopedics, entire product ... for upper and lower extremities. Consisting of more ...
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/bkw8kk/pharmaceutical ) has ... in North America 2015-2019" report to their offering. ... North America to grow at a CAGR ... International regulations regarding safe drug delivery are enforced by ... adoption of sustainable packaging. Various raw materials such as ...
Breaking Medicine Technology:EndoChoice to Report Second Quarter 2015 Financial Results on August 6, 2015 2Flower Orthopedics cleared to enter the European Union 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2North American Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 3
... The Chinese Biopharmaceutical Association-USA (CBA) successfully held its 16 ... US.   With the theme of ... the conference drew nearly 500 attendees with ... exhibited at the conference, including Chinese leading biotech parks, ...
... The Council on Competitiveness, in partnership with the ... case study today highlighting the potential for high performance ... facing the health care industry. The report, " ... the Delivery of ,Smarter, Health Care ," studies ...
Cached Medicine Technology:Chinese Biopharmaceutical Association Successfully Holds 16th Annual Conference 2Chinese Biopharmaceutical Association Successfully Holds 16th Annual Conference 3Council on Competitiveness Showcases Power of High Performance Computing in Case Study with GNS Healthcare 2
6 mm x 23 mm blunt, double-edged blade. Flat handle....
Double-ended. Blades set at 45 and 90 degrees. Hexagonal handle....
3.5 mm blade. Round handle. Designated most popular model or size....
2 mm wide x 3 mm long, tapered handle. Angled 45 degrees. Round handle....
Medicine Products: